The cost and value of cancer medicines in Ontario, Canada
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2024
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Canada (MeSH)
- Cost-Benefit Analysis (MeSH)
- Humans (MeSH)
- Neoplasms (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Ontario (MeSH)
published in
- The Lancet Oncology Journal